Voglibose & Metformin Tablets

Form: Tablets

Strength: (Voglibose 0.2/0.3 mg) + (Metformin 500/850 mg)

Reference Brands: Voglimet, Voglinorm-M, Volibo-M, Vogli-Met(India/Japan)

Category: Diabetes

Voglibose + Metformin combination tablets (0.2/0.3 mg Voglibose with 500/850 mg Metformin) are not approved by the FDA (USA) or EMA (EU) for marketing. Voglibose lacks regulatory approval in both regions due to limited clinical data per Western standards. However, this fixed-dose combination is widely approved and marketed in India, Japan, and other parts of Asia for managing Type 2 Diabetes Mellitus, particularly for postprandial hyperglycemia. Brands like Voglimet, Voglinorm-M, and Volibo-M are common. For sourcing, global B2B buyers can access compliant manufacturers through platforms like Pharmatradz.com.